Regeneron turns to IT to accelerate drug discovery
CIO Business Intelligence
NOVEMBER 4, 2022
We’ll work with those scientists and actually build the computer models and go run it, and it can be anything from sub-physical particle imaging to protein folding,” he says. “In In other cases, it’s more of a standard computational requirement and we help them provide the data in the right formats.
Let's personalize your content